Obesity, clinical, and genetic predictors for glycemic progression in Chinese patients with type 2 diabetes: A cohort study using the Hong Kong Diabetes Register and Hong Kong Diabetes Biobank

Diabetes-Related Complications and Mortality in Patients With Young-Onset Latent Autoimmune Diabetes: A 14-Year Analysis of the Prospective Hong Kong Diabetes Register

(2019) Andrea O.Y. Luk et al.   DIABETES CARE

Genetic Variants inCPA6andPRPF31Are Associated With Variation in Response to Metformin in Individuals With Type 2 Diabetes

(2018) Daniel M. Rotroff et al.   DIABETES

Aspects of Multicomponent Integrated Care Promote Sustained Improvement in Surrogate Clinical Outcomes: A Systematic Review and Meta-analysis

(2018) Lee Ling Lim et al.   DIABETES CARE

Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes

(2018) Anubha Mahajan et al.   NATURE GENETICS

Implication of critical pharmacokinetic gene variants on therapeutic response to metformin in Type 2 diabetes

(2018) Nagaraja M Phani et al.   PHARMACOGENOMICS

Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables

(2018) Emma Ahlqvist et al.   Lancet Diabetes & Endocrinology

Genetic risk score for adult body mass index associations with childhood and adolescent weight gain in an African population

(2018) Richard J. Munthali et al.   Genes and Nutrition

Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations

(2018) Amit V. Khera et al.   NATURE GENETICS

Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes

(2018) Angli Xue et al.   Nature Communications

Type 2 diabetes genetic loci informed by multi-trait associations point to disease mechanisms and subtypes: A soft clustering analysis

(2018) Miriam S. Udler et al.   PLOS MEDICINE

Progression of diabetic kidney disease and trajectory of kidney function decline in Chinese patients with Type 2 diabetes

(2018) Guozhi Jiang et al.   KIDNEY INTERNATIONAL

BMI as a Modifiable Risk Factor for Type 2 Diabetes: Refining and Understanding Causal Estimates Using Mendelian Randomization

(2016) Laura J. Corbin et al.   DIABETES

CYP2C8 and SLCO1B1 Variants and Therapeutic Response to Thiazolidinediones in Patients With Type 2 Diabetes

(2016) Adem Y. Dawed et al.   DIABETES CARE

Polymorphism of Organic Cation Transporter 2 Improves Glucose-Lowering Effect of Metformin via Influencing Its Pharmacokinetics in Chinese Type 2 Diabetic Patients

(2015) Wolin Hou et al.   Molecular Diagnosis & Therapy

Genetic studies of body mass index yield new insights for obesity biology

(2015) Adam E. Locke et al.   NATURE

IRS1 G972R Missense Polymorphism Is Associated With Failure to Oral Antidiabetes Drugs in White Patients With Type 2 Diabetes From Italy

(2014) S. Prudente et al.   DIABETES

A pharmacogenetic association between a variation in calpain 10 (CAPN10) gene and the response to metformin treatment in patients with type 2 diabetes

(2014) Ivan Tkáč et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Adiponectin Gene Polymorphism rs2241766 T/G Is Associated with Response to Pioglitazone Treatment in Type 2 Diabetic Patients from Southern China

(2014) Hong Yang et al.   PLoS One

Causes of type 2 diabetes in China

(2014) Ronald Ching Wan Ma et al.   Lancet Diabetes & Endocrinology

A New Equation to Estimate Glomerular Filtration Rate

(2013) Andrew S. Levey et al.   ANNALS OF INTERNAL MEDICINE

Factors influencing insulin acceptance among type 2 diabetes mellitus patients in a primary care clinic: a qualitative exploration

(2013) Hasliza Abu Hassan et al.   BMC Family Practice

Clinical and Genetic Determinants of Progression of Type 2 Diabetes: A DIRECT Study

(2013) Kaixin Zhou et al.   DIABETES CARE

Influence of Genetic Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Sulfonylurea Drugs

(2012) Hongmei Xu et al.   CURRENT DRUG METABOLISM

A gene variant near ATM is significantly associated with metformin treatment response in type 2 diabetes: a replication and meta-analysis of five cohorts

(2012) N. van Leeuwen et al.   DIABETOLOGIA

KCNJ11 gene E23K variant and therapeutic response to sulfonylureas

(2011) Martin Javorsky et al.   European Journal of Internal Medicine

Common Variants in 40 Genes Assessed for Diabetes Incidence and Response to Metformin and Lifestyle Intervention in the Diabetes Prevention Program

(2010) K. A. Jablonski et al.   DIABETES

Genetic Variants of the Protein Kinase C-β 1 Gene and Development of End-Stage Renal Disease in Patients With Type 2 Diabetes

(2010) Ronald C. W. Ma   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Influence of CYP2C9 and CYP2C19 genetic polymorphisms on pharmacokinetics and pharmacodynamics of gliclazide in healthy Chinese Han volunteers

(2010) H. Shao et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Loss-of-Function CYP2C9 Variants Improve Therapeutic Response to Sulfonylureas in Type 2 Diabetes: A Go-DARTS Study

(2009) K Zhou et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

The consequences of delaying insulin initiation in UK type 2 diabetes patients failing oral hyperglycaemic agents: a modelling study

(2009) Gordon Goodall et al.   BMC Endocrine Disorders

Type 2 diabetes-associated genetic variants discovered in the recent genome-wide association studies are related to gestational diabetes mellitus in the Korean population

(2008) Y. M. Cho et al.   DIABETOLOGIA

Diabetes-Related Microvascular and Macrovascular Diseases in the Physical Therapy Setting

(2008) W Todd Cade   PHYSICAL THERAPY